Clobetasol Propionate Ointment Usp, 0.05%
Common brands: Clobetasol Propionate, Byqlovi, Clobetasol Propionate (Emollient), Clobetasol Propionate Anda, Clobetasol Propionate Emollient Formulation
Top reporter: Encube Ethicals, Inc.
Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
9,774
Total Reports
5,374
Serious Reports
430
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.40%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Clobetasol Propionate Ointment Usp, 0.05%.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DRUG INEFFECTIVE | 1,018 | |
| 2 | PRURITUS | 817 | |
| 3 | OFF LABEL USE | 660 | |
| 4 | RASH | 603 | |
| 5 | PSORIASIS | 528 | |
| 6 | PRODUCT USE IN UNAPPROVED INDICATION | 489 | |
| 7 | FATIGUE | 487 | |
| 8 | HEADACHE | 465 | |
| 9 | NAUSEA | 414 | |
| 10 | DIARRHOEA | 410 | |
| 11 | ARTHRALGIA | 388 | |
| 12 | PAIN | 377 | |
| 13 | DRY SKIN | 347 | |
| 14 | SKIN EXFOLIATION | 344 | |
| 15 | ERYTHEMA | 323 | |
| 16 | CONDITION AGGRAVATED | 306 | |
| 17 | PRODUCT DOSE OMISSION ISSUE | 296 | |
| 18 | DYSPNOEA | 293 | |
| 19 | INJECTION SITE PAIN | 276 | |
| 20 | DIZZINESS | 266 | |
| 21 | PAIN IN EXTREMITY | 266 | |
| 22 | DERMATITIS ATOPIC | 264 | |
| 23 | FALL | 245 | |
| 24 | ECZEMA | 238 | |
| 25 | VOMITING | 224 | |
| 26 | PYREXIA | 222 | |
| 27 | INSOMNIA | 219 | |
| 28 | MALAISE | 219 | |
| 29 | ASTHENIA | 202 | |
| 30 | WEIGHT DECREASED | 198 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.